| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |